biotech Archives · TechNode

Allan Gabor

BEYOND Expo | Merck China president Allan Gabor shares insights on AI and biomedicine

by Ward Zhou Sep 22, 2022Sep 26, 2022

Among the 64 stocks held by Hillhouse Capital in the first quarter of this year, 24 were Chinese firms, accounting for about 38% of the total amount.

Insights | What do Hillhouse Capital’s investments tell us about China tech stocks?

by Jasmine Zheng and Ward Zhou Jun 7, 2022Jul 8, 2022

BEYOND Virtual | William Haseltine: Next 20 years an era of enormous innovation

by TechNode Staff Nov 9, 2021Nov 9, 2021

delivery drivers investment covid-19 meituan ecommerce, covid-19, entertainment investment

China tech investments sank 31% in Q1

by Wei Sheng Apr 7, 2020Apr 7, 2020

AI drug development Covid-19

AI drug development platform raises $10 million in Series A

by Chris Udemans Mar 16, 2020Mar 17, 2020

With Chinese Characteristics

Conditional approval for China-developed Alzheimer’s therapy drug

by Miles Goscha Nov 5, 2019Mar 17, 2020

Shanghai biotech I-Mab plans US IPO as part of China drug strategy

by Miles Goscha Oct 31, 2019Mar 17, 2020

Cancer drug firm Ascentage Pharma shares soar following Hong Kong IPO

by Miles Goscha Oct 29, 2019

Insilico Medicine nabs $200 million AI-powered drug discovery deal

by Miles Goscha Oct 10, 2019Mar 17, 2020

Ping An Technology AI predicts flu outbreaks with 90% accuracy

by Miles Goscha Sep 24, 2019Sep 24, 2019

We've recently sent you an authentication link. Please, check your inbox!

Sign in with a password below, or sign in using a link.

Get a link sent to your email to sign in instantly, or sign in using a password.

Subscribe to our newsletters: Every Wednesday and Friday, TechNode’s Briefing newsletter delivers a roundup of the most important news in China tech, straight to your inbox.

Sign in with a link

Lost your password?

Sign in with a password

OR

By signing up, you agree to our privacy policy.